ELAN

ELAN

USD

Elanco Animal Health Incorporated Common Stock

$22.500+0.270 (1.215%)

Reaalajas hind

Healthcare
Drug Manufacturers - Specialty & Generic
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$22.230

Kõrge

$22.840

Madal

$22.150

Maht

12.80M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

11.2B

Tööstusharu

Drug Manufacturers - Specialty & Generic

Riik

United States

Kauplemisstatistika

Keskmine maht

7.18M

Börs

NYQ

Valuuta

USD

52 nädala vahemik

Madal $8.02Praegune $22.500Kõrge $22.96

Seotud uudised

PR Newswire

Elanco Announces Expansion of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) and Credelio™ (lotilaner) Labels, Offering Protection Against Lyme Disease and an Emerging Tick Species

Elanco Animal Health Incorporated (NYSE: ELAN) today announced label expansions for two of its leading canine prescription parasiticides, Credelio...

Vaata rohkem
Elanco Announces Expansion of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) and Credelio™ (lotilaner) Labels, Offering Protection Against Lyme Disease and an Emerging Tick Species
PR Newswire

Elanco's Credelio™ (lotilaner) Receives First Ever FDA Emergency Use Authorization (EUA) against New World Screwworm (NWS) in Dogs

Elanco Animal Health Incorporated (NYSE: ELAN) today announced it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug...

Vaata rohkem
Elanco's Credelio™ (lotilaner) Receives First Ever FDA Emergency Use Authorization (EUA) against New World Screwworm (NWS) in Dogs
Analyst Upgrades

JP Morgan Upgrades Elanco Animal Health to Overweight, Raises Price Target to $24

JP Morgan analyst Chris Schott upgrades Elanco Animal Health from Neutral to Overweight and raises the price target from $18 to $24.

Vaata rohkem
JP Morgan Upgrades Elanco Animal Health to Overweight, Raises Price Target to $24